Press release
Glioma Treatment Market Study Highlights How Industry Demand Is Evolving
Glioma Treatment Market
Projected Market Size of the Glioma Treatment Market by 2030
The glioma treatment market is expected to experience considerable growth and reach a valuation of $7.44 billion by 2030. This represents a compound annual growth rate (CAGR) of 6.8%. Several factors underpin this optimistic forecast, including the integration of precision oncology, the advent of novel targeted therapies, a stronger emphasis on improving survival rates, growth in specialty oncology clinics, and the adoption of personalized treatment plans. Key trends anticipated to drive growth during this period include a rising preference for combination therapies, increasing focus on early surgical interventions, expanded use of targeted drug treatments, optimization of radiation therapy, and enhanced strategies for long-term disease management.
The glioma treatment market size has grown strongly in recent years. It will grow from $5.37 billion in 2025 to $5.72 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to advances in neurosurgery, growth of radiation oncology, chemotherapy adoption, improved diagnostic imaging, expansion of cancer care facilities.
Download a free sample of the glioma treatment market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10689&type=smp&utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR
Emerging Players Driving Innovations in the Glioma Treatment Market
A number of prominent companies are actively shaping the glioma treatment landscape. Leading players include Merck & Co Inc., Amgen Inc., F Hoffmann-La Roche AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Arbor Pharmaceuticals LLC, Amneal Pharmaceuticals Inc., Karyopharm Therapeutics Inc., Bristol-Myers Squibb Co., Rigel Pharmaceuticals Inc., Sumitomo Dainippon Pharma Oncology Inc., Emcure Pharmaceuticals Ltd., Novartis AG, AstraZeneca plc, Eli Lilly and Company, Sanofi S.A., Johnson & Johnson, AbbVie Inc., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Bayer AG, Gilead Sciences Inc., Ipsen Pharma, Eisai Co. Ltd., Genentech Inc., Iovance Biotherapeutics Inc., and Agios Pharmaceuticals Inc.
A notable development occurred in February 2023 when Kite, a US-based global biopharmaceutical firm, acquired Tmunity Therapeutics. Although the financial details remain undisclosed, this acquisition significantly expands Kite's research capabilities in cell therapy. It brings in new pipeline assets and access to both pre-clinical and clinical programs, including an innovative 'armored' CAR T technology platform aimed at enhancing the anti-tumor effects of CAR-T therapies. Tmunity Therapeutics specializes in creating novel treatments for diffuse intrinsic pontine glioma, a particularly challenging brain cancer.
View the full glioma treatment market report:
https://www.thebusinessresearchcompany.com/report/glioma-treatment-global-market-report?utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR
Current Trends Shaping the Glioma Treatment Industry
The glioma treatment sector is witnessing a surge in the adoption of innovative therapies such as immunotherapy, designed to boost the immune system's ability to fight cancer. This approach is gaining traction as companies strive to improve patient outcomes by targeting tumors more effectively. For example, in June 2024, Servier Pharmaceuticals, headquartered in France, received FDA approval for VORANIGO (vorasidenib) tablets. This milestone marks the approval of the first targeted treatment for Grade 2 IDH-mutant glioma. Vorasidenib functions as a dual inhibitor of isocitrate dehydrogenase (IDH) 1 and 2 mutations, frequently found in glioma patients. These mutations increase levels of 2-hydroxyglutarate (2-HG), a metabolite that promotes tumor growth. By blocking these enzymes, vorasidenib reduces 2-HG production and potentially slows tumor progression.
Additional Evident Shifts in Glioma Treatment Approaches
Alongside targeted therapies, there is growing emphasis on personalized medicine and combination treatments that utilize multiple modalities to achieve better efficacy. Advances in surgical techniques and radiation therapy optimization are also contributing to improved management of glioma cases. The overall trend is toward treatments tailored specifically to the genetic and molecular profile of each tumor, helping to maximize patient survival and quality of life.
Detailed Segment Breakdown of the Glioma Treatment Market
This report categorizes the glioma treatment market based on various parameters:
1) By Type:
- Low-Grade
- High-Grade
2) By Disease:
- Glioblastoma Multiforme
- Anaplastic Astrocytoma
- Anaplastic Oligodendroglioma
- Other Diseases
3) By Route of Administration:
- Oral
- Parenteral
- Other Routes
4) By Treatment Type:
- Surgery
- Radiation Therapy
- Chemotherapy
- Targeted Drug Therapy
- Other Treatments
5) By End-User:
- Hospitals
- Specialty Clinics
- Other End Users
Further subcategories within the low-grade segment include astrocytoma, oligodendroglioma, and mixed glioma, while the high-grade segment encompasses glioblastoma multiforme, anaplastic astrocytoma, and anaplastic oligodendroglioma. This detailed segmentation highlights the diverse approaches and treatment options available within the glioma therapy landscape.
What's new in our 2026 market reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glioma Treatment Market Study Highlights How Industry Demand Is Evolving here
News-ID: 4607703 • Views: …
More Releases from The Business Research Company
Hair Drug Testing Market Outlook Signals Expansion To $3.4 Billion Through 2030
The hair drug testing sector is on the verge of remarkable expansion, driven by technological advancements and increasing demand across various industries. As concerns about workplace safety and compliance intensify, the market is responding with innovative solutions that promise greater accuracy and efficiency. Below, we explore the market's anticipated size, key players, prevailing trends, and segmentation details shaping this evolving landscape.
Anticipated Growth and Market Size of the Hair Drug Testing…
Gynecology Robotic Surgery Market Report 2026 Market Outlook Supported By A Fore …
The gynecology robotic surgery market is on track for significant expansion over the coming years, driven by technological advances and shifting clinical practices. As surgical robotics becomes increasingly sophisticated and widely adopted, the landscape of gynecological care is evolving toward less invasive and more precise procedures. The following sections explore the market's size, key players, emerging trends, and segmentation in detail.
Projected Market Growth and Future Outlook for Gynecology Robotic Surgery…
Growth Hormone Deficiency Market Insights Highlight Segment Expansion And Market …
The market for growth hormone deficiency treatments is poised for notable expansion in the coming years, driven by advances in medical research and evolving patient care approaches. As personalized therapies gain traction and technology enhances treatment monitoring, this sector is set to experience dynamic growth and innovation. Let's explore the current market size, key players, prevailing trends, and important segments shaping the future of this industry.
Projected Market Size and Growth…
Graft Versus Host Disease (GVHD) Treatment Market Report Evaluates Growth Driver …
The graft versus host disease (GVHD) treatment market is positioned for significant expansion in the coming years, driven by advances in therapies and growing demand for effective management options. This overview highlights the current market outlook, major players, emerging trends, and key segments shaping the future of GVHD treatment worldwide.
Projected Growth and Market Size of the Graft Versus Host Disease (GVHD) Treatment Sector
The GVHD treatment market is anticipated…
More Releases for Treatment
Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market…
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,…
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any…
